What is he best known for?
The fields of study he is best known for:
Timothy A.J. Haystead mainly investigates Biochemistry, Molecular biology, Phosphorylation, Mitogen-activated protein kinase kinase and Protein kinase A.
His Molecular biology research is multidisciplinary, incorporating elements of Proteome, Genome, Affinity chromatography, Purine and Protein sequencing.
His Phosphorylation research integrates issues from EIF4E, Eukaryotic Initiation Factor-4E and Kinase.
He combines subjects such as MAP2K7, Cyclin-dependent kinase 2, MAP kinase kinase kinase and Protein tyrosine phosphatase with his study of Mitogen-activated protein kinase kinase.
His MAP2K7 research focuses on subjects like Cyclin-dependent kinase 9, which are linked to ASK1.
His Protein kinase A research includes themes of Phosphatase and Protein subunit.
His most cited work include:
- Effects of the tumour promoter okadaic acid on intracellular protein phosphorylation and metabolism (761 citations)
- PHAS-I as a link between mitogen-activated protein kinase and translation initiation. (610 citations)
- Activation of mitogen-activated protein kinase kinase by v-Raf in NIH 3T3 cells and in vitro (571 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Biochemistry, Phosphorylation, Molecular biology, Kinase and Cell biology.
His is involved in several facets of Biochemistry study, as is seen by his studies on Mitogen-activated protein kinase kinase, MAP2K7, Protein phosphorylation, Affinity chromatography and Biotin.
The study incorporates disciplines such as Cyclin-dependent kinase 2 and MAP kinase kinase kinase in addition to Mitogen-activated protein kinase kinase.
His Phosphorylation study combines topics in areas such as Endocrinology and Internal medicine.
His work deals with themes such as Staurosporine and Proteome, which intersect with Molecular biology.
His studies in Phosphatase integrate themes in fields like Protein subunit and Myosin.
He most often published in these fields:
- Biochemistry (34.47%)
- Phosphorylation (25.73%)
- Molecular biology (25.24%)
What were the highlights of his more recent work (between 2016-2021)?
- Cancer research (12.62%)
- Kinase (22.82%)
- Breast cancer (6.80%)
In recent papers he was focusing on the following fields of study:
Timothy A.J. Haystead focuses on Cancer research, Kinase, Breast cancer, Hsp90 inhibitor and Cancer.
Kinase is a subfield of Cell biology that Timothy A.J. Haystead explores.
His Breast cancer research is multidisciplinary, incorporating perspectives in Stage, Molecular imaging, In vivo and Hsp90.
His Ubiquitin study also includes fields such as
- Kidney cancer that connect with fields like Phosphorylation,
- Function which connect with Enzyme.
The concepts of his Antibody study are interwoven with issues in Fatty acid synthase and Biochemistry.
Timothy A.J. Haystead specializes in Biochemistry, namely Crosstalk.
Between 2016 and 2021, his most popular works were:
- Immunogenic cancer cell death selectively induced by near infrared photoimmunotherapy initiates host tumor immunity. (71 citations)
- Takinib, a Selective TAK1 Inhibitor, Broadens the Therapeutic Efficacy of TNF-α Inhibition for Cancer and Autoimmune Disease (49 citations)
- Methods to validate Hsp90 inhibitor specificity, to identify off-target effects, and to rethink approaches for further clinical development. (43 citations)
In his most recent research, the most cited papers focused on:
The scientist’s investigation covers issues in Cancer research, Hsp90, Immunology, Hsp90 inhibitor and In vivo.
His Cancer research research incorporates themes from Protein phosphatase 2, Cell signaling, Signal transduction, Extracellular and Idiopathic pulmonary fibrosis.
His Hsp90 research is multidisciplinary, relying on both Kinase, Cell biology and Virology.
His work carried out in the field of Immunology brings together such families of science as Malignancy, Cell and Cancer.
His Hsp90 inhibitor research incorporates elements of Plasmodium falciparum, Plasmodium, Malaria, Parasite load and Breast cancer.
He has included themes like Clinical trial, Tumor cells, Phenotype, Stage and Metabolism in his In vivo study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
